A Phase I dose-escalation trial, conducted at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and multiple sites nationwide, has shown that a new gene therapy treatment for high-grade gliomas — the most aggressive brain tumors — is safe and improves patient survival. Having passed this milestone, the treatment will move on to more advanced trials.
Minimally Invasive Spine SurgeryWatch Video >>
Back pain? Visit the Spine Institute.Get Started
What do our patients have to say?Find Out
More than 50 years of innovative care.Learn More
Continuing an upward trend, the University of Miami Miller School of Medicine reached a record-breaking fundraising total for the fiscal year 2016. According to standards set by the Council for Advancement and Support of Education (CASE), the Miller School raised an unprecedented $159.8 million for the fiscal year, which ended May 31.